| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |